Redesigned website at http://www.roosterbio.comoffers enhanced functionality and tools to support informed industrialized regenerative medicine supply chain solutions.
FREDERICK, MD. (PRWEB) JANUARY 21, 2020
RoosterBio, a leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, has made its online buying experience more efficient with the launch of the newly redesigned roosterbio.com website. The website offers a radically simplified, user-friendly experience with improved navigation and functionality, while allowing its global customers to gain deeper knowledge of RoosterBio’s standardized regenerative medicine products and biomanufacturing solutions.
“Our primary goal during the redesign process was to create a more customer-centric and responsive resource across all platforms to allow us to expand into global marketplaces. Specifically, we wanted to improve the informed online buying experience to grow our relationships with customers,” said RoosterBio CEO Margot Connor. “Our website is key to beginning a conversation that allows us to address the supply chain challenges our customers face in advancing their cell and gene therapies. We believe the new site gives visitors a more comprehensive understanding of how RoosterBio can help get our customers’ products to the clinic more cost-effectively and more quickly than traditional methods without sacrificing quality.”
The refreshed and streamlined website integrates a new Knowledge Center with in-depth information about products not made available online before to allow visitors to make confident purchasing inquiries and decisions. New product features include: the addition of required products, reasons why RoosterBio designed the product, lot specifications, product application information, associated publications and additional recommended products to streamline processes.
“Our pioneering journey continues as we create new ways to address our customers needs. It’s the continuous loop of analyzing, implementing and evolving that allows us to stay at the forefront of developing cutting-edge regenerative technology solutions,” added Connor.
The website will be frequently updated with blog posts, publications, and company updates. Feedback, questions or comments are welcome at [email protected].
About RoosterBio, Inc.
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high-volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization into the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit roosterbio.com.
“Our primary goal during the redesign process was to create a more customer-centric and responsive resource across all platforms to allow us to expand into global marketplaces.” – Margot Connor, RoosterBio CEO
